Released on = April 10, 2007, 5:14 pm

Press Release Author = Martin/ WISBIOMD

Industry = Biotech

Press Release Summary = Reagent kits for T cell receptor clonality assay for
anti-cancer drug and vaccine development

Press Release Body = Title: Simplified TCR clonality assay kits for vaccine
development and immunology research

A line of RT-PCR based quick assay kits for T cell receptor clonality analysis is
now available
from WISBiomed. The kit includes RNA extraction, reverse transcription, and
polymerase chain
reaction amplification, as well as the component for electrophoresis. This kit
contains all the needed
reagents, optimized primers for 22 Vbeta CDR3s and fine-tuned protocol.

Starting from less than 100,000 cells, one can complete the assay and obtain reliable
results within a day. The improved sensitivity and simplified procedures cause these
products to differ
from other home-made assays.

With the time and reagents saved with these quick assay Super TCRexpress kits,
researchers and
scientists in vaccine development, anti-cancer drug development and immunology enjoy
the
new tools offered by WISBiomed.

WISBiomed also announces the new lowered prices for all the TCRexpress reagent kits,
TCRexpress
and Super TCRexpress kits. See website www.wisbiomed.com for detail.


Web Site = http://ec.wisbiomed.com

Contact Details = WISBiomed
120 Boothbay Avenue
San Mateo, CA 94404
650-242-8368